SFE-171 has been used to fortify milk and dairy prod ucts for several years. This product presented high bioavailability in human beings and similar bioavail ability as ferrous sulfate in animals (1-3). It was found to be inert with regard to the sensorial properties of the foods to which it was added (4), and its toxicity was demonstrated to be substantially lower than that of fer rous sulfate (5) . On the other hand, ferric orthophos phate is also known to produce few compatibility prob lems with foods, but it has low iron bioavailability (6) and was therefore included in this work only for com parative purposes.
Milk and dairy products have high nutritional value but low iron content. Therefore they are attractive food vehicles for iron fortification, since they are massively consumed by the general population and especially by children, which is a high-risk group with regard to iron deficiency. For these reasons and for its good palatabil ity, Petit-Suisse cheese was selected as a main food vehi cle for the iron sources in study.
The iron bioavailability (BioFe) of SFE-171 and ferric orthophosphate were compared in the present work to that of ferrous sulfate (reference standard) and conse quently was also expressed in terms of Relative Biological Value (RBV). Diet 4: Based on nonfortified Petit-Suisse cheese. All diets were prepared with the same cheese ("Gamadim" from Strauss Dairies, Israel). SFE-171 and ferric orthophosphate were added to the cheese during the manufacturing process, and ferrous sulphate was mixed with the diet in our laboratory. To fulfill the nu tritional requirements of the rats, other nutrients were used to prepare these diets ( Table 1 ). The iron concen tration of the fortified diets was consequently reduced nearly to 15mg Fe/kg in the final mix.
The diets were prepared daily and freely administered to the different groups of rats, which are henceforth re ferred to according to the number of the diet. Only these diets were given to the animals as solid nourishment, and the amount of the consumed food was daily regis tered. The iron concentration of each diet was regularly determined by the Ferrozine technique modified for foods (8) . The rats were also allowed free access to deionized water (Ametek, USA).
After 23 days, each animal was weighed again and treated with 1,500 LU. of heparin per kg body, anaes thetised with diethyl ether, and sacrificed by bleeding through retro-orbital sinus puncture; a few mL of blood being collected per animal. The hemoglobin concentra tion in the collected blood of every rat was once again determined by the cyanomethahemoglobin method (7). Each animal liver was entirely removed, washed with The BioFe of the studied sources are also given in Table 3 , showing that the iron provided by SFE-171 has similar bioavailability to that of ferrous sulfate and higher than ferric orthophosphate.
In the same table it is observed that the LIC of group 1 is higher, though not significantly different, than the LIC of groups 2 and 3, pointing to a similar storing capability of the studied sources at the administered doses.
In a previous work we demonstrated that the indus trial SFE-171 has bioavailability similar to ferrous sul fate (9) . In the present work, a specific food vehicle was used in a similar protocol, and the same evidence is pro vided. It can therefore be concluded that SFE-171 re sists the technological process to which Petit-Suisse cheese is submitted during its industrial production, having an iron bioavailability similar to the reference standard (ferrous sulphate) and higher than ferric or thophosphate.
